Inputs and outputs of insulin receptor

Abstract

The insulin receptor (IR) is an important hub in insulin signaling and its activation is tightly regulated. Upon insulin stimulation, IR is activated through autophosphorylation, and consequently phosphorylates several insulin receptor substrate (IRS) proteins, including IRS1-6, Shc and Gab1. Certain adipokines have also been found to activate IR. On the contrary, PTP, Grb and SOCS proteins, which are responsible for the negative regulation of IR, are characterized as IR inhibitors. Additionally, many other proteins have been identified as IR substrates and participate in the insulin signaling pathway. To provide a more comprehensive understanding of the signals mediated through IR, we reviewed the upstream and downstream signal molecules of IR, summarized the positive and negative modulators of IR, and discussed the IR substrates and interacting adaptor proteins. We propose that the molecular events associated with IR should be integrated to obtain a better understanding of the insulin signaling pathway and diabetes.

Keywords

insulin / insulin receptor / signaling

References

[1] Adeghate E (2008) Visfatin: structure, function and relation to diabetes mellitus and other dysfunctions. Curr Med Chem15: 1851-1862

[2] Ahmad F, Goldstein BJ (1997) Functional association between the insulin receptor and the transmembrane protein-tyrosine phosphatase LAR in intact cells. J Biol Chem272: 448-457

[3] Ahmed Z, Smith BJ, Pillay TS (2000) The APS adapter protein couples the insulin receptor to the phosphorylation of c-Cbl and facilitates ligand-stimulated ubiquitination of the insulin receptor. FEBS Lett475: 31-34

[4] Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, Mustelin T (2004) Protein tyrosine phosphatases in the human genome. Cell117: 699-711

[5] Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK, Moller NP (2001) Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol Cell Biol21: 7117-7136

[6] Andersen JN, Jansen PG, Echwald SM, Mortensen OH, Fukada T, Del Vecchio R, Tonks NK, Moller NP (2004) A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage. FASEB J18: 8-30

[7] Auberger P, Falquerho L, Contreres JO, Pages G, Le Cam G, Rossi B, Le Cam A (1989) Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell58: 631-640

[8] Baltensperger K, Karoor V, Paul H, Ruoho A, Czech MP, Malbon CC (1996) The beta-adrenergic receptor is a substrate for the insulin receptor tyrosine kinase. J Biol Chem271: 1061-1064

[9] Baron V, Calleja V, Ferrari P, Alengrin F, Van Obberghen E (1998) p125Fak focal adhesion kinase is a substrate for the insulin and insulin-like growth factor-I tyrosine kinase receptors. J Biol Chem273: 7162-7168

[10] Benaim G, Villalobo A (2002) Phosphorylation of calmodulin. Functional implications. Eur J Biochem269: 3619-3631

[11] Bollag GE, Roth RA, Beaudoin J, Mochly-Rosen D, Koshland DE Jr (1986) Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. Proc Natl Acad Sci USA83: 5822-5824

[12] Boucher J, Quilliot D, Praderes JP, Simon MF, Gres S, Guigne C, Prevot D, Ferry G, Boutin JA, Carpene C (2005) Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression. Diabetologia48: 569-577

[13] Braiman L, Alt A, Kuroki T, Ohba M, Bak A, Tennenbaum T, Sampson SR (2001) Insulin induces specific interaction between insulin receptor and protein kinase C delta in primary cultured skeletal muscle. Mol Endocrinol15: 565-574

[14] Buelt MK, Shekels LL, Jarvis BW, Bernlohr DA (1991) In vitro phosphorylation of the adipocyte lipid-binding protein (p15) by the insulin receptor. Effects of fatty acid on receptor kinase and substrate phosphorylation. J Biol Chem266: 12266-12271

[15] Cai D, Dhe-Paganon S, Melendez PA, Lee J, Shoelson SE (2003) Two new substrates in insulin signaling, IRS5/DOK4 and IRS6/ DOK5. J Biol Chem278: 25323-25330

[16] Chen J, Sadowski HB, Kohanski RA, Wang LH (1997) Stat5 is a physiological substrate of the insulin receptor. Proc Natl Acad Sci USA94: 2295-2300

[17] Costanzo BV, Trischitta V, Di Paola R, Spampinato D, Pizzuti A, Vigneri R, Frittitta L (2001) The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). Diabetes50: 831-836

[18] Dadke S, Kusari A, Kusari J (2001) Phosphorylation and activation of protein tyrosine phosphatase (PTP) 1B by insulin receptor. Mol Cell Biochem221: 147-154

[19] Delahaye L, Rocchi S, Van Obberghen E (2000) Potential involvement of FRS2 in insulin signaling. Endocrinology141: 621-628

[20] Delibegovic M, Bence KK, Mody N, Hong EG, Ko HJ, Kim JK, Kahn BB, Neel BG (2007) Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B. Mol Cell Biol27: 7727-7734

[21] Delibegovic M, Zimmer D, Kauffman C, Rak K, Hong EG, Cho YR, Kim JK, Kahn BB, Neel BG, Bence KK (2009) Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B) improves metabolic syndrome and attenuates diet-induced endoplasmic reticulum stress. Diabetes58: 590-599

[22] Di Cristofano A, Carpino N, Dunant N, Friedland G, Kobayashi R, Strife A, Wisniewski D, Clarkson B, Pandolfi PP, Resh MD (1998) Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. J Biol Chem273: 4827-4830

[23] Dubois MJ, Bergeron S, Kim HJ, Dombrowski L, Perreault M, Fournes B, Faure R, Olivier M, Beauchemin N, Shulman GI (2006) The SHP-1 protein tyrosine phosphatase negatively modulates glucose homeostasis. Nat Med12: 549-556

[24] Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van Obberghen E (2000) SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem275: 15985-15991

[25] Fantin VR, Sparling JD, Slot JW, Keller SR, Lienhard GE, Lavan BE (1998) Characterization of insulin receptor substrate 4 in human embryonic kidney 293 cells. J Biol Chem273: 10726-10732

[26] Formisano P, Najjar SM, Gross CN, Philippe N, Oriente F, Kern-Buell CL, Accili D, Gorden P (1995) Receptor-mediated internalization of insulin. Potential role of pp120/HA4, a substrate of the insulin receptor kinase. J Biol Chem270: 24073-24077

[27] Galic S, Klingler-Hoffmann M, Fodero-Tavoletti MT, Puryer MA, Meng TC, Tonks NK, Tiganis T (2003) Regulation of insulin receptor signaling by the protein tyrosine phosphatase TCPTP. Mol Cell Biol23: 2096-2108

[28] Galic S, Hauser C, Kahn BB, Haj FG, Neel BG, Tonks NK, Tiganis T (2005) Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. MolCell Biol25: 819-829

[29] Goustin AS, Abou-Samra AB (2011) The “thrifty” gene encoding Ahsg/Fetuin-A meets the insulin receptor: Insights into the mechanism of insulin resistance. Cell Signal23: 980-990

[30] Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes48: 1270-1274

[31] Grupe A, Alleman J, Goldfine ID, Sadick M, Stewart TA (1995) Inhibition of insulin receptor phosphorylation by PC-1 is not mediated by the hydrolysis of adenosine triphosphate or the generation of adenosine. J Biol Chem270: 22085-22088

[32] Gual P, Baron V, Lequoy V, Van Obberghen E (1998) Interaction of Janus kinases JAK-1 and JAK-2 with the insulin receptor and the insulin-like growth factor-1 receptor. Endocrinology139: 884-893

[33] Hanke S, Mann M (2009) The phosphotyrosine interactome of the insulin receptor family and its substrates IRS-1 and IRS-2. Mol Cell Proteomics8: 519-534

[34] Hansen H, Svensson U, Zhu J, Laviola L, Giorgino F, Wolf G, Smith RJ, Riedel H (1996) Interaction between the Grb10 SH2 domain and the insulin receptor carboxyl terminus. J Biol Chem271: 8882-8886

[35] Hashimoto N, Feener EP, Zhang WR, Goldstein BJ (1992) Insulin receptor protein-tyrosine phosphatases. Leukocyte common antigen-related phosphatase rapidly deactivates the insulin receptor kinase by preferential dephosphorylation of the receptor regulatory domain. J Biol Chem267: 13811-13814

[36] Hayashi H, Nishioka Y, Kamohara S, Kanai F, Ishii K, Fukui Y, Shibasaki F, Takenawa T, Kido H, Katsunuma N (1993) The alpha-type 85-kDa subunit of phosphatidylinositol 3-kinase is phosphorylated at tyrosines 368, 580, and 607 by the insulin receptor. J Biol Chem268: 7107-7117

[37] Holt LJ, Siddle K (2005) Grb10 and Grb14: enigmatic regulators of insulin action-and more? Biochem J388: 393-406

[38] Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science274: 1377-1379

[39] Hresko RC, Mueckler M (2000) A novel 68-kDa adipocyte protein phosphorylated on tyrosine in response to insulin and osmotic shock. J Biol Chem275: 18114-18120

[40] Hresko RC, Mueckler M (2002) Identification of pp68 as the tyrosinephosphorylated form of SYNCRIP/NSAP1. A cytoplasmic RNAbinding protein. J Biol Chem277: 25233-25238

[41] Itani SI, Zhou Q, Pories WJ, MacDonald KG, Dohm GL (2000) Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes49: 1353-1358

[42] Jornayvaz FR, Shulman GI (2012) Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance. Cell Metab15: 574-584

[43] Jornayvaz FR, Birkenfeld AL, Jurczak MJ, Kanda S, Guigni BA, Jiang DC, Zhang D, Lee HY, Samuel VT, Shulman GI (2011) Hepatic insulin resistance inmicewith hepatic overexpression of diacylglycerol acyltransferase 2. Proc Natl Acad Sci USA108: 5748-5752

[44] Joyal JL, Crimmins DL, Thoma RS, Sacks DB (1996) Identification of insulin-stimulated phosphorylation sites on calmodulin. Biochemistry35: 6267-6275

[45] Kalabay L, Cseh K, Pajor A, Baranyi E, Csakany GM, Melczer Z, Speer G, Kovacs M, Siller G, Karadi I (2002) Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes. Eur J Endocrinol147: 243-248

[46] Karoor V, Wang L, Wang HY, Malbon CC (1998) Insulin stimulates sequestration of beta-adrenergic receptors and enhanced association of beta-adrenergic receptors with Grb2 via tyrosine 350. J Biol Chem273: 33035-33041

[47] Kasus-Jacobi A, Bereziat V, Perdereau D, Girard J, Burnol AF (2000) Evidence for an interaction between the insulin receptor and Grb7. A role for two of its binding domains, PIR and SH2. Oncogene19: 2052-2059

[48] Kato K, Nishimasu H, Okudaira S, Mihara E, Ishitani R, Takagi J, Aoki J, Nureki O (2012) Crystal structure of Enpp1, an extracellular glycoprotein involved in bone mineralization and insulin signaling. Proc Natl Acad Sci USA109: 16876-16881

[49] Kharitonenkov A, Schnekenburger J, Chen Z, Knyazev P, Ali S, Zwick E, White M, Ullrich A (1995) Adapter function of proteintyrosine phosphatase 1D in insulin receptor/insulin receptor substrate-1 interaction. J Biol Chem270: 29189-29193

[50] Kong M, Wang CS, Donoghue DJ (2002) Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation. J Biol Chem277: 15962-15970

[51] Kotani K, Wilden P, Pillay TS (1998) SH2-Balpha is an insulinreceptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase. Biochem J335(Pt 1): 103-109

[52] Krebs DL, Uren RT, Metcalf D, Rakar S, Zhang JG, Starr R, De Souza DP, Hanzinikolas K, Eyles J, Connolly LM (2002) SOCS-6 binds to insulin receptor substrate 4, and mice lacking the SOCS-6 gene exhibit mild growth retardation. Mol Cell Biol22: 4567-4578

[53] Kwon YK, Jang HJ, Kole S, He HJ, Bernier M (2003) Role of the pleckstrin homology domain of PLCgamma1 in its interaction with the insulin receptor. J Cell Biol163: 375-384

[54] Lammers R, Bossenmaier B, Cool DE, Tonks NK, Schlessinger J, Fischer EH, Ullrich A (1993) Differential activities of protein tyrosine phosphatases in intact cells. J Biol Chem268: 22456-22462

[55] Laurino JP, Colca JR, Pearson JD, DeWald DB, McDonald JM (1988) The in vitro phosphorylation of calmodulin by the insulin receptor tyrosine kinase. Arch Biochem Biophys265: 8-21

[56] Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR, Lienhard GE (1997a) A novel 160-kDa phosphotyrosine protein in insulintreated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem272: 21403-21407

[57] Lavan BE, Lane WS, Lienhard GE (1997b) The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem272: 11439-11443

[58] Le MN, Kohanski RA, Wang LH, Sadowski HB (2002) Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor. Mol Endocrinol16: 2764-2779

[59] Lehr S, Kotzka J, Herkner A, Sikmann A, Meyer HE, Krone W, Muller-Wieland D (2000) Identification of major tyrosine phosphorylation sites in the human insulin receptor substrate Gab-1 by insulin receptor kinase in vitro. Biochemistry39: 10898-10907

[60] Lemay S, Davidson D, Latour S, Veillette A (2000) Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling. Mol Cell Biol20: 2743-2754

[61] Li Y, Soos TJ, Li X, Wu J, Degennaro M, Sun X, Littman DR, Birnbaum MJ, Polakiewicz RD (2004) Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101). J Biol Chem279: 45304-45307

[62] Lin WH, Huang CJ, Liu MW, Chang HM, Chen YJ, Tai TY, Chuang LM (2001) Cloning, mapping, and characterization of the human sorbin and SH3 domain containing 1 (SORBS1) gene: a protein associated with c-Abl during insulin signaling in the hepatoma cell line Hep3B. Genomics74: 12-20

[63] Liu F, Roth RA (1995) Grb-IR: a SH2-domain-containing protein that binds to the insulin receptor and inhibits its function. Proc Natl Acad Sci USA92: 10287-10291

[64] Ma YM, Tao RY, Liu Q, Li J, Tian JY, Zhang XL, Xiao ZY, Ye F (2011) PTP1B inhibitor improves both insulin resistance and lipid abnormalities in vivo and in vitro. Mol Cell Biochem357: 65-72

[65] Maddux BA, Goldfine ID (2000) Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit. Diabetes49: 13-19

[66] Masse K, Bhamra S, Allsop G, Dale N, Jones EA (2010) Ectophosphodiesterase/ nucleotide phosphohydrolase (Enpp) nucleotidases: cloning, conservation and developmental restriction. Int J Dev Biol54: 181-193

[67] Mathews ST, Chellam N, Srinivas PR, Cintron VJ, Leon MA, Goustin AS, Grunberger G (2000) Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol164: 87-98

[68] McAteer JB, Prudente S, Bacci S, Lyon HN, Hirschhorn JN, Trischitta V, Florez JC, Consortium E (2008) The ENPP1 K121Q polymorphism is associated with type 2 diabetes in European populations: evidence from an updated meta-analysis in 42, 042 subjects. Diabetes57: 1125-1130

[69] Mitchell F (2012) Obesity: glypican-4: role in insulin signalling. Nat Rev Endocrinol8: 505

[70] Moodie SA, Alleman-Sposeto J, Gustafson TA (1999) Identification of the APS protein as a novel insulin receptor substrate. J Biol Chem274: 11186-11193

[71] Mooney RA, Senn J, Cameron S, Inamdar N, Boivin LM, Shang Y, Furlanetto RW (2001) Suppressors of cytokine signaling-1 and-6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J Biol Chem276: 25889-25893

[72] Moore AF, Jablonski KA, Mason CC, McAteer JB, Arakaki RF, Goldstein BJ, Kahn SE, Kitabchi AE, Hanson RL, Knowler WC (2009) The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program. J Clin Endocrinol Metab94: 449-455

[73] Nouaille S, Blanquart C, Zilberfarb V, Boute N, Perdereau D, Roix J, Burnol AF, Issad T (2006) Interaction with Grb14 results in sitespecific regulation of tyrosine phosphorylation of the insulin receptor. EMBO Rep7: 512-518

[74] O’Neill TJ, Zhu Y, Gustafson TA (1997) Interaction of MAD2 with the carboxyl terminus of the insulin receptor but not with the IGFIR. Evidence for release from the insulin receptor after activation. J Biol Chem272: 10035-10040

[75] Patti ME, Sun XJ, Bruening JC, Araki E, Lipes MA, White MF, Kahn CR (1995) 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice. J Biol Chem270: 24670-24673

[76] Picardi PK, Calegari VC, Prada PO, Moraes JC, Araujo E, Marcondes MC, Ueno M, Carvalheira JB, Velloso LA, Saad MJ (2008) Reduction of hypothalamic protein tyrosine phosphatase improves insulin and leptin resistance in diet-induced obese rats. Endocrinology149: 3870-3880

[77] Pillay TS, Sasaoka T, Olefsky JM (1995) Insulin stimulates the tyrosine dephosphorylation of pp125 focal adhesion kinase. J Biol Chem270: 991-994

[78] Poy MN, Ruch RJ, Fernstrom MA, Okabayashi Y, Najjar SM (2002a) Shc and CEACAM1 interact to regulate the mitogenic action of insulin. J Biol Chem277: 1076-1084

[79] Poy MN, Yang Y, Rezaei K, Fernstrom MA, Lee AD, Kido Y, Erickson SK, Najjar SM (2002b) CEACAM1 regulates insulin clearance in liver. Nat Genet30: 270-276

[80] Rosenzweig T, Aga-Mizrachi S, Bak A, Sampson SR (2004) Src tyrosine kinase regulates insulin-induced activation of protein kinaseC (PKC) delta in skeletal muscle. Cell Signal16: 1299-1308

[81] Rui L, Carter-Su C (1998) Platelet-derived growth factor (PDGF) stimulates the association of SH2-Bbeta with PDGF receptor and phosphorylation of SH2-Bbeta. J Biol Chem273: 21239-21245

[82] Sacks DB, McDonald JM (1988) Insulin-stimulated phosphorylation of calmodulin by rat liver insulin receptor preparations. J Biol Chem263: 2377-2383

[83] Sacks DB, McDonald JM (1989) Calmodulin as substrate for insulinreceptor kinase. Phosphorylation by receptors from rat skeletal muscle. Diabetes38: 84-90

[84] Sacks DB, Fujita-Yamaguchi Y, Gale RD, McDonald JM (1989) Tyrosine-specific phosphorylation of calmodulin by the insulin receptor kinase purified from human placenta. Biochem J263: 803-812

[85] Sacks DB, Davis HW, Crimmins DL, McDonald JM (1992) Insulinstimulated phosphorylation of calmodulin. Biochem J286(Pt 1): 211-216

[86] Sacks DB, Mazus B, Joyal JL (1995) The activity of calmodulin is altered by phosphorylation: modulation of calmodulin function by the site of phosphate incorporation. Biochem J312(Pt 1): 197-204

[87] Sadowski CL, Choi TS, Le M, Wheeler TT, Wang LH, Sadowski HB (2001) Insulin Induction of SOCS-2 and SOCS-3 mRNA expression in C2C12 Skeletal Muscle Cells Is Mediated by Stat5*. J Biol Chem276: 20703-20710

[88] Salmeen A, Andersen JN, Myers MP, Tonks NK, Barford D (2000) Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. Mol Cell6: 1401-1412

[89] Samuel VT, Liu ZX, Wang A, Beddow SA, Geisler JG, Kahn M, Zhang XM, Monia BP, Bhanot S, Shulman GI (2007) Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J Clin Invest117: 739-745

[90] Sanchez-Margalet V, Najib S (1999) p68 Sam is a substrate of the insulin receptor and associates with the SH2 domains of p85 PI3K. FEBS Lett455: 307-310

[91] Sanchez-Margalet V, Najib S (2001) Sam68 is a docking protein linking GAP and PI3K in insulin receptor signaling. Mol Cell Endocrinol183: 113-121

[92] Sanchez-Margalet V, Gonzalez-Yanes C, Najib S, Fernandez-Santos JM, Martin-Lacave I (2003) The expression of Sam68, a protein involved in insulin signal transduction, is enhanced by insulin stimulation. Cell Mol Life Sci60: 751-758

[93] Sasaoka T, Kobayashi M (2000) The functional significance of Shc in insulin signaling as a substrate of the insulin receptor. Endocr J47: 373-381

[94] Saville MK, Houslay MD (1994) Phosphorylation of calmodulin on Tyr99 selectively attenuates the action of calmodulin antagonists on type-I cyclic nucleotide phosphodiesterase activity. Biochem J299(Pt 3): 863-868

[95] Sawka-Verhelle D, Filloux C, Tartare-Deckert S, Mothe I, Van Obberghen E (1997) Identification of Stat 5B as a substrate of the insulin receptor. Eur J Biochem250: 411-417

[96] Sawka-Verhelle D, Tartare-Deckert S, Decaux JF, Girard J, Van Obberghen E (2000) Stat 5B, activated by insulin in a Jakindependent fashion, plays a role in glucokinase gene transcription. Endocrinology141: 1977-1988

[97] Sciacchitano S, Taylor SI (1997) Cloning, tissue expression, and chromosomal localization of the mouse IRS-3 gene. Endocrinology138: 4931-4940

[98] Seely BL, Staubs PA, Reichart DR, Berhanu P, Milarski KL, Saltiel AR, Kusari J, Olefsky JM (1996) Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes45: 1379-1385

[99] Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW, Mooney RA (2003) Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem278: 13740-13746

[100] Shome K, Vasudevan C, Romero G (1997) ARFproteinsmediate insulindependent activation of phospholipase D. Curr Biol7: 387-396

[101] Smith FM, Holt LJ, Garfield AS, Charalambous M, Koumanov F, Perry M, Bazzani R, Sheardown SA, Hegarty BD, Lyons RJ (2007) Mice with a disruption of the imprinted Grb10 gene exhibit altered body composition, glucose homeostasis, and insulin signaling during postnatal life. Mol Cell Biol27: 5871-5886

[102] Srinivas PR, Wagner AS, Reddy LV, Deutsch DD, Leon MA, Goustin AS, Grunberger G (1993) Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level. Mol Endocrinol7: 1445-1455

[103] Storz P, Doppler H, Pfizenmaier K, Muller G (1999) Insulin selectively activates STAT5b, but not STAT5a, via a JAK2-independent signalling pathway in Kym-1 rhabdomyosarcoma cells. FEBS Lett464: 159-163

[104] Suchy D, Labuzek K, Machnik G, Kozlowski M, Okopien B (2013) SOCS and diabetes-ups and downs of a turbulent relationship. Cell Biochem Funct31: 181-195

[105] Sun XJ, Crimmins DL, Myers MG Jr, Miralpeix M, White MF (1993) Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol Cell Biol13: 7418-7428

[106] Taniguchi CM, Emanuelli B, Kahn CR (2006) Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol7: 85-96

[107] Tanti JF, Ceppo F, Jager J, Berthou F (2012) Implication of inflammatory signaling pathways in obesity-induced insulin resistance. Front Endocrinol ( Lausanne)3: 181

[108] Tonks NK (2006) Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol7: 833-846

[109] Uchida T, Matozaki T, Noguchi T, Yamao T, Horita K, Suzuki T, Fujioka Y, Sakamoto C, Kasuga M (1994) Insulin stimulates the phosphorylation of Tyr538 and the catalytic activity of PTP1C, a protein tyrosine phosphatase with Src homology-2 domains. J Biol Chem269: 12220-12228

[110] Ueki K, Kondo T, Kahn CR (2004) Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol24: 5434-5446

[111] Ussar S, Bezy O, Bluher M, Kahn CR (2012) Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine. Diabetes61: 2289-2298

[112] Van Horn DJ, Myers MG Jr, Backer JM (1994) Direct activation of the phosphatidylinositol 3’-kinase by the insulin receptor. J Biol Chem269: 29-32

[113] Waltermann C, Klipp E (2011) Information theory based approaches to cellular signaling. Biochim Biophys Acta1810: 924-932

[114] Wang J, Riedel H (1998) Insulin-like growth factor-I receptor and insulin receptor association with a Src homology-2 domaincontaining putative adapter. J Biol Chem273: 3136-3139

[115] Wang LL, Richard S, Shaw AS (1995) P62 association with RNA is regulated by tyrosine phosphorylation. J Biol Chem270: 2010-2013

[116] Wang X, Chen L, Maures TJ, Herrington J, Carter-Su C (2004) SH2- B is a positive regulator of nerve growth factor-mediated activation of the Akt/Forkhead pathway in PC12 cells. J Biol Chem279: 133-141

[117] Wang L, Balas B, Christ-Roberts CY, Kim RY, Ramos FJ, Kikani CK, Li C, Deng C, Reyna S, Musi N (2007) Peripheral disruption of the Grb10 gene enhances insulin signaling and sensitivity in vivo. Mol Cell Biol27: 6497-6505

[118] Waters SB, Pessin JE (1996) Insulin receptor substrate 1 and 2 (IRS1 and IRS2): what a tangled web we weave. Trends Cell Biol6: 1-4

[119] White MF, Kahn CR (1994) The insulin signaling system. J Biol Chem269: 1-4

[120] Wick MJ, Dong LQ, Hu D, Langlais P, Liu F (2001) Insulin receptormediated p62dok tyrosine phosphorylation at residues 362 and 398 plays distinct roles for binding GTPase-activating protein and Nck and is essential for inhibiting insulin-stimulated activation of Ras and Akt. J Biol Chem276: 42843-42850

[121] Wick KR, Werner ED, Langlais P, Ramos FJ, Dong LQ, Shoelson SE, Liu F (2003) Grb10 inhibits insulin-stimulated insulin receptor substrate (IRS)-phosphatidylinositol 3-kinase/Akt signaling pathway by disrupting the association of IRS-1/IRS-2 with the insulin receptor. J Biol Chem278: 8460-8467

[122] Williams JP, Jo H, Sacks DB, Crimmins DL, Thoma RS, Hunnicutt RE, Radding W, Sharma RK, McDonald JM (1994) Tyrosinephosphorylated calmodulin has reduced biological activity. Arch Biochem Biophys315: 119-126

[123] Wong EC, Sacks DB, Laurino JP, McDonald JM (1988) Characteristics of calmodulin phosphorylation by the insulin receptor kinase. Endocrinology123: 1830-1836

[124] Xu H, LeeK W, Goldfarb M (1998) Novel recognition motif on fibroblast growth factor receptor mediates direct association and activation of SNTadapter proteins. J Biol Chem273: 17987-17990

[125] Yokouchi M, Suzuki R, Masuhara M, Komiya S, Inoue A, Yoshimura A (1997) Cloning and characterization of APS, an adaptor molecule containing PH and SH2 domains that is tyrosine phosphorylated upon B-cell receptor stimulation. Oncogene15: 7-15

[126] Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ (2002) Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem277: 50230-50236

[127] Zeng L, Sachdev P, Yan L, Chan JL, Trenkle T, McClelland M, Welsh J, Wang LH (2000) Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation. Mol Cell Biol20: 9212-9224

[128] Zhang W, Zong CS, Hermanto U, Lopez-Bergami P, Ronai Z, Wang LH (2006) RACK1 recruits STAT3 specifically to insulin and insulin-like growth factor 1 receptors for activation, which is important for regulating anchorage-independent growth. Mol Cell Biol26: 413-424

RIGHTS & PERMISSIONS

2014 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.